News & Announcements

  ATTENTION!!! 

  

Call for nominations for the IMPAACT Network Executive Committee

(click here for more information)

 


                

  ATTENTION!!! 

  

Call for nominations for International Vice Chair for the IMPAACT Vaccine/Immuno-based Therapy Scientific Committee

(click here for more information)

 


 

  ATTENTION!!! 

  

Call for nominations for a Domestic Investigator for the IMPAACT Vaccine/Immuno-based Therapy Scientific Committee 

(click here for more information)


 

 NIAID Blog About Restructuring of the Networks

 

NIAID DAIDS is now in the process of seeking input from the research and HIV/AIDS communities in regards to the restructuring of the HIV/AIDS clinical trials networks. As of yesterday, a series of blogs were posted on AIDS.gov that will address various aspects of the network restructuring, such as NIAID’s clinical research priority areas, the structure of the new networks, and the relationship between network leadership groups and clinical research sites.  These blogs are intended to promote dialogue and discussion among constituents.  Please feel free to share this information with people who may be interested in joining the discussion.

 

Link:  http://blog.aids.gov/


 FYI
Request For Applications (RFA) Number: RFA-AI-10-009
Martin Delaney Collaboratory: Towards an HIV Cure
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-009.html

 


 1077HS Activation and Accrual Report, Dated 07/22/10 (.xls)

 

Sites Activated

Number Screened

Number Enrolled

Totals for NIAID Sites

31

12

9

Totals for NICHD Sites

19

9

4

Totals for All Sites

50

21

13


The Kilimanjaro Christian Medical Centre-Duke University Kilimanjaro AIDS
Program, Moshi, wishes to announce one position for a Clinical Research Site Coordinator at the KCMC Campus, in Moshi, Tanzania.  Read More...

 

 

  

Call for nominations for International Vice Chair of the IMPAACT Vaccine/Immuno-based Therapy Scientific Committee

(click here for more information)

 

Call for nominations for International Vice Chair for the IMPAACT Vaccine/Immuno-based Therapy Scientific Committee 

 

(click here for more information)


 Admin. Supplement for HIV Implementation Science in PEPFAR Settings 

To: IMPAACT CTU Principal Investigators and CRS Leaders 

From: Louis Grue, IMPAACT Operations Center 

Date: Wednesday, April 07, 2010 

Re: FYI-Administrative Supplement for HIV Implementation Science in PEPFAR Settings  

 


Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)

 

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-005.html

 


 

 
It is important to be aware of potential drug interactions with HIV medications while caring for patients on HAART and enrolled in clinical trials, particularly pharmacokinetic studies.  Prohibited and precautionary medication drug lists are included in the research protocols or protocol MOPS.
 

Here is a list of websites that members of the Pharmacy Resource Committee have found to be helpful...Pharmacy Resource Committee Update - February 3, 2010

 


 
CROI 2010 Accepted Abstracts List 
*The Lay Summaries of the presented abstracts will be made available after February 19, 2010

 

 


 

 

 OLDER POSTED ANNOUNCEMENTS   

 

 

 

 

Administrative Supplement for HIV Implementation Science in PEPFAR Settings

 

To: IMPAACT CTU Principal Investigators and CRS Leaders

From: Louis Grue, IMPAACT Operations Center

Date: Wednesday, April 07, 2010

Re: FYI-Administrative Supplement for HIV Implementation Science in PEPFAR Settings